O'Shaughnessy Asset Management’s Oramed Pharmaceuticals ORMP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$495K	Sell	102,962 -13,401	-12%	-$53.3K	﹤0.01%	1606
2026 Q1	$396K	Buy	+116,363	New	+$395K	﹤0.01%	1638
2021 Q1	–	Sell	-141	Closed	-$1K	–	2435
2020 Q4	$1K	Buy	+141	New	+$459	﹤0.01%	1977
2020 Q3	–	Sell	-41	Closed	–	–	1962
2020 Q2	$0	Buy	+41	New	+$138	﹤0.01%	1847

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

O'Shaughnessy Asset Management's ORMP Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Oramed Pharmaceuticals (ORMP) stake by 12% in Q2 2026, selling an estimated $53.3K and leaving 102,962 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

O'Shaughnessy Asset Management first reported a position in ORMP in Q2 2020 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

O'Shaughnessy Asset Management held 102,962 shares of Oramed Pharmaceuticals worth $495K as of Q2 2026.
O'Shaughnessy Asset Management sold 13,401 Oramed Pharmaceuticals shares in Q2 2026, an estimated $53.3K.
Oramed Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1606 holding.
O'Shaughnessy Asset Management first reported a position in Oramed Pharmaceuticals in Q2 2020 and has held it in 4 quarters since.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.